Top Markets
Coin of the day
Imagin Medical Inc. Imagin Medical Inc.

Imagin Medical Inc.

IME
Rank in Stocks #40569
Imagin Medical Inc. is a company dedicated to developing cutting-edge surgical... Imagin Medical Inc. is a company dedicated to developing cutting-edge surgical imaging technology, with a primary focus on treatments for bladder cancer. The firm is currently in the process of creating its i/Blue Imaging System, which is specifically designed to address the diagnostic and therapeutic requirements of urologists managing Bladder Cancer (BLC). This enterprise, which was established in 1986, maintains its corporate headquarters in Vancouver, Canada.
Share Price
$0.01100905
Last synced: 2024-07-23
Market Cap
$119.23K
Change (1 day)
-0.72%
Change (1 year)
0.00%
Country
CA
Trade Imagin Medical Inc. (IME)

Category

P/E ratio for Imagin Medical Inc. (IME)
P/E ratio as of 2026 TTM: 0
According to Imagin Medical Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Imagin Medical Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
33.99 -
US
33.47 -
US
21.39 -
IE
18.84 -
US
49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.